60
Participants
Start Date
July 15, 2023
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Hyperbaric oxygen therapy (HBOT)
"HBOT is a medical treatment employed for various conditions. It entails breathing 100% oxygen within a pressurized chamber known as a hyperbaric chamber. This oxygen-rich environment promotes healing and aids in combating specific infections.~In this study, the investigators will administer HBOT using a hyperbaric chamber set to 2 times the normal atmospheric pressure, indicated as 2 atmosphere absolute (ATA). This pressure surge enhances oxygen dissolution into the bloodstream, surpassing levels achievable at sea level. The pressure will be raised incrementally, followed by HBOT sessions lasting for a total of 90 minutes. The 90-minute sessions include brief 5-minute intervals for ambient air every 20 minutes to ensure safety and comfort. Treatment will be conducted five days a week over eight weeks.~Supervised by competent healthcare professionals, HBOT is considered safe, with potential side effects primarily stemming from heightened pressure and, in rare cases, oxygen toxicity."
RECRUITING
Charité - Universitätsmedizin Berlin, Berlin
KLINIK BAVARIA Kreischa
UNKNOWN
Vivantes Klinikum im Friedrichshain
UNKNOWN
Charite University, Berlin, Germany
OTHER